# US 2023/0399612 A1 · Method for the generation of neurospheres

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0399612 A1
- Document ID: US20230399612A1
- Status: Published application
- Kind: A1
- Application number: 18/034,780
- Filed: 2021-11-02
- Published: 2023-12-14
- Earliest claimed: 2020-10-30
- Assignees: Kugelmeiers AG
- Applicants: Kugelmeiers Ltd.
- Inventors: Jay GOPALAKRISHNAN
- Web page: https://patentgrep.com/patent/US20230399612A1

## CPC

- C12N 5/0618: {Cells of the nervous system}
- C12N 5/0622: {Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells}
- C12M 23/12: {Well or multiwell plates (C12M25/04 takes precedence)}
- C12N 5/0697: {Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691)}
- G01N 33/5058: {Neurological cells}
- C12N 2506/03: from non-embryonic pluripotent stem cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2513/00: 3D culture
- C12N 2535/10: Patterned coating
- G01N 33/5088: {of vertebrates}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method for producing a plurality of homogeneous neurospheres, said method comprising: providing pluripotent cells; seeding said pluripotent cells into a cell culture device comprising at least one compartment comprising a plurality of microwells; and culturing said pluripotent cells in said cell culture device under conditions that allow the cells to form neurospheres.

## Claims

### Claim 1

A method for producing a plurality of homogeneous neurospheres, said method comprising:
providing pluripotent cells;
seeding said pluripotent stem cells in a cell culture device comprising a plurality of compartments comprising a plurality of microwells; and
culturing said pluripotent stem cells in said cell culture device under conditions that allow the cells to form neurospheres,
wherein the pluripotent cells do not form embryoid bodies.

### Claim 2

A method for producing a plurality of homogeneous brain organoids, said method comprising:
providing pluripotent cells;
seeding said pluripotent cells in a cell culture device comprising a plurality of compartments comprising a plurality of microwells;
culturing said pluripotent cells in said cell culture device under conditions that allow the cells to form neurospheres;
transferring the formed neurospheres into 3D culture dishes; and
culturing said neurospheres in said 3D culture dishes under conditions that allow said neurospheres to develop into brain organoids
wherein the pluripotent cells do not form embryoid bodies.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the brain organoids develop within less than 50 days.

### Claim 4 (depends on 1)

The method according to claim 1, wherein in each compartment, the plurality of microwells is arranged in a way that the compartment bottom is completely covered in microwells and wherein the compartment bottom is essentially free of flat surfaces.

### Claim 5 (depends on 1)

The method according to claim 1, wherein each microwell has the same volume.

### Claim 6 (depends on 1)

The method according to claim 1, wherein each microwell has a pyramid shape having a rounded tip and rounded edges between the side walls of the pyramid.

### Claim 7 (depends on 1)

The method according to claim 1, wherein during the step of seeding, each microwell within a compartment receives the same number of pluripotent cells.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the pluripotent cells are human pluripotent cells, preferably human induced pluripotent stem cells.

### Claim 9

Brain organoids comprising microglial cells, expressing mature neuronal markers and preferably having a maximum size of 1.5 mm.

### Claim 10 (depends on 9)

The brain organoids according to claim 9, wherein the brain organoids show reduced stress levels, e.g. as assessed by the expression level of stress markers such as PGK1, ARCN1 and GORASP2.

### Claim 11 (depends on 9)

The brain organoids according to claim 9, wherein the brain organoids show electrically active glutaminergic and GABAergic neurons and/or are positive for neural stem cell markers, in particular PAX6, SOX2, Nestin; differentiated early neuronal markers, in particular DCX and TLU1; and/or late neuronal markers, in particular Synapsin-1, GAD67, Tau, MAP2, CTIP, alpha-Synuclein and VGIut-1.

### Claim 12 (depends on 9)

The brain organoids according to claim 9 for use in the treatment or diagnosis of neurodevelopmental diseases, neurodegenerative diseases, infectious brain diseases, brain cancer, brain tumors, stroke or brain diseases linked to autoimmune conditions.

### Claim 13 (depends on 9)

The brain organoids according to claim 9, wherein the brain organoids can be frozen and re-cultured with a viability of at least 90%.

### Claim 14 (depends on 9)

A method for producing human brain proteins, wherein the human brain proteins are produced by the brain organoids according to claim 9.

### Claim 15 (depends on 9)

A method for a drug screening, said method comprising using the brain organoids according to claim 9.
